Acute tubular necrosis
| Acute Tubular Necrosis | |
|---|---|
| Synonyms | ATN |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Oliguria, fatigue, nausea, vomiting, confusion |
| Complications | Acute kidney injury, chronic kidney disease |
| Onset | Sudden |
| Duration | Variable |
| Types | N/A |
| Causes | Ischemia, nephrotoxins |
| Risks | Sepsis, surgery, hypotension, contrast agents |
| Diagnosis | Urinalysis, blood tests, renal biopsy |
| Differential diagnosis | Prerenal azotemia, glomerulonephritis, interstitial nephritis |
| Prevention | N/A |
| Treatment | Supportive care, dialysis |
| Medication | N/A |
| Prognosis | Variable, depends on underlying cause and treatment |
| Frequency | Common in hospitalized patients |
| Deaths | N/A |
Acute Tubular Necrosis (ATN) is a medical condition involving the death of tubular epithelial cells that form the renal tubules of the kidneys. This condition can lead to acute kidney injury (AKI) or kidney failure.
Causes[edit]
ATN is most commonly caused by ischemia (lack of oxygen) to the kidney area. This can occur from low blood pressure, septic shock, major surgery, trauma, or severe hemorrhage. Other causes include nephrotoxic damage from medications or poisons, and severe infections such as sepsis.
Symptoms[edit]
Symptoms of ATN can vary depending on the severity of the condition. They may include decreased urine output, fluid retention leading to swelling, drowsiness, shortness of breath, fatigue, confusion, nausea, and irregular heartbeat.
Diagnosis[edit]
Diagnosis of ATN is typically made through a combination of clinical history, physical examination, and laboratory tests. Urinalysis may show abnormal levels of proteins and cells in the urine. Blood tests may reveal elevated levels of creatinine and urea, indicating impaired kidney function.
Treatment[edit]
Treatment for ATN primarily involves treating the underlying cause and providing supportive care. This may include fluid management, medications to control symptoms, and in severe cases, dialysis may be required.
Prognosis[edit]
The prognosis for ATN can vary widely depending on the severity of the condition and the patient's overall health. Some patients may recover normal kidney function with treatment, while others may progress to chronic kidney disease or end-stage renal disease.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian